These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


166 related items for PubMed ID: 28704559

  • 21. Dual-pore mesoporous carbon@silica composite core-shell nanospheres for multidrug delivery.
    Fang Y, Zheng G, Yang J, Tang H, Zhang Y, Kong B, Lv Y, Xu C, Asiri AM, Zi J, Zhang F, Zhao D.
    Angew Chem Int Ed Engl; 2014 May 19; 53(21):5366-70. PubMed ID: 24764082
    [Abstract] [Full Text] [Related]

  • 22. Synthesis of Silica Based Nanoparticles Against the Proliferation of Human Prostate Cancer.
    Durmus IM, Deveci I, Karakurt S.
    Anticancer Agents Med Chem; 2021 May 19; 21(18):2553-2562. PubMed ID: 33557739
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Fabrication of acetylated carboxymethylcellulose coated hollow mesoporous silica hybrid nanoparticles for nucleolin targeted delivery to colon adenocarcinoma.
    Nejabat M, Mohammadi M, Abnous K, Taghdisi SM, Ramezani M, Alibolandi M.
    Carbohydr Polym; 2018 Oct 01; 197():157-166. PubMed ID: 30007600
    [Abstract] [Full Text] [Related]

  • 25. Polyoxometalate-biomolecule conjugates: a new approach to create hybrid drugs for cancer therapeutics.
    Yang HK, Cheng YX, Su MM, Xiao Y, Hu MB, Wang W, Wang Q.
    Bioorg Med Chem Lett; 2013 Mar 01; 23(5):1462-6. PubMed ID: 23337597
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. VEGFR-2 inhibiting effect and molecular modeling of newly synthesized coumarin derivatives as anti-breast cancer agents.
    Ahmed EY, Abdel Latif NA, El-Mansy MF, Elserwy WS, Abdelhafez OM.
    Bioorg Med Chem; 2020 Mar 01; 28(5):115328. PubMed ID: 31992477
    [Abstract] [Full Text] [Related]

  • 29. Yolk-type Au@Fe3O4@C nanospheres for drug delivery, MRI and two-photon fluorescence imaging.
    Zhou YM, Wang HB, Gong M, Sun ZY, Cheng K, Kong XK, Guo Z, Chen QW.
    Dalton Trans; 2013 Jul 21; 42(27):9906-13. PubMed ID: 23695613
    [Abstract] [Full Text] [Related]

  • 30. Engineering Mesoporous Silica Nanoparticles for Targeted Alpha Therapy against Breast Cancer.
    Pallares RM, Agbo P, Liu X, An DD, Gauny SS, Zeltmann SE, Minor AM, Abergel RJ.
    ACS Appl Mater Interfaces; 2020 Sep 09; 12(36):40078-40084. PubMed ID: 32805833
    [Abstract] [Full Text] [Related]

  • 31. Activation of Intrinsic Apoptosis and G1 Cell Cycle Arrest by a Triazole Precursor, N-(4-chlorophenyl)-2-(4-(3,4,5-trimethoxybenzyloxy)benzoyl)-hydrazinecarbothioamide in Breast Cancer Cell Line.
    Arulnathan SB, Leong KH, Ariffin A, Kareem HS, Cheah KKH.
    Anticancer Agents Med Chem; 2020 Sep 09; 20(9):1072-1086. PubMed ID: 32188392
    [Abstract] [Full Text] [Related]

  • 32. Increased Toxicity of Doxorubicin Encapsulated into pH-Responsive Poly(β-Amino Ester)-Functionalized MCM-41 Silica Nanoparticles.
    Ávila-Ortega A, Carrillo-Cocom LM, Olán-Noverola CE, Nic-Can GI, Vilchis-Nestor AR, Talavera-Pech WA.
    Curr Drug Deliv; 2020 Sep 09; 17(9):799-805. PubMed ID: 32723272
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. A Bottom-Up Synthesis Approach to Silver Nanoparticles Induces Anti-Proliferative and Apoptotic Activities Against MCF-7, MCF-7/TAMR-1 and MCF-10A Human Breast Cell Lines.
    Zulkifli NI, Muhamad M, Mohamad Zain NN, Tan WN, Yahaya N, Bustami Y, Abdul Aziz A, Nik Mohamed Kamal NNS.
    Molecules; 2020 Sep 22; 25(18):. PubMed ID: 32971740
    [Abstract] [Full Text] [Related]

  • 35. Discovery of polyoxometalate-based HDAC inhibitors with profound anticancer activity in vitro and in vivo.
    Dong Z, Tan R, Cao J, Yang Y, Kong C, Du J, Zhu S, Zhang Y, Lu J, Huang B, Liu S.
    Eur J Med Chem; 2011 Jun 22; 46(6):2477-84. PubMed ID: 21481498
    [Abstract] [Full Text] [Related]

  • 36. Amino Acid-functionalized hollow mesoporous silica nanospheres as efficient biocompatible drug carriers for anticancer applications.
    Ezzati N, Mahjoub AR, Abolhosseini Shahrnoy A, Syrgiannis Z.
    Int J Pharm; 2019 Dec 15; 572():118709. PubMed ID: 31629730
    [Abstract] [Full Text] [Related]

  • 37. On the Cytotoxicity of Chiral Ruthenium Complexes Containing Sulfur Amino Acids against Breast Tumor Cells (MDA-231 and MCF-7).
    Leite CM, de Araujo-Neto JH, Corrêa RS, Colina-Vegas L, Martínez-Otero D, Martins PR, Silva CG, Batista AA.
    Anticancer Agents Med Chem; 2021 Dec 15; 21(9):1172-1182. PubMed ID: 32838726
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.